Sun, Mar 1, 2015, 2:36 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Advanced Medical Isotope Corporation Message Board

  • Apr 29, 2013 2:42 PM Flag

    Darwinian Selection In Medical Devices: Brachytherapy Offers Investors Hope

    I believe RadioGel is a pioneering technology in the brachytherapy sector because it holds marked clinical advantages over traditional implants. Specifically, RadioGel's list of clinical advantages include but are not limited to the following:

    - Yttrium-90 has a half-life of only 2.7 days

    - Yttrium-90 has considerably clinical evidence showing efficacy against inoperable liver tumors

    - Ytrrium-90 has shown promise in reducing tumors in a variety of cancer types

    - Yttrium- 90 is a beta-emitter, making it safer for clinicians and patients alike

    - No metal casings to deal with

    - Gel is biodegradable and can thus be easily reabsorbed by the body

    - Gel forms a solid lattice that holds the Yttrium-90 in place and is thermally reversible

    To put this into context, I believe that patients given a choice between a surgically implanted medical casing with a long-lived isotope such as iridium-192 or a gel that dissolves in a few days, the patient is going to choose RadioGel every time. Given that the clinical research thus far is painting a promising picture for yttrium-90 in a diverse array of cancers, I believe RadioGel has a strong chance to become the standard of care in brachytherapy procedures. Unfortunately, I wasn't able to get an estimate on the timeframe for FDA review of RadioGel, but instead was informed by the agency that they cannot currently comment on a device that is "under-review". Based on historical precedence, however, I think RadioGel could be approved before the end of 2013.

    Sentiment: Strong Buy

0.0012+0.0004(+50.00%)Feb 27 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Aruba Networks, Inc.
NASDAQFri, Feb 27, 2015 4:00 PM EST
Vulcan Materials Company
NYSEFri, Feb 27, 2015 4:00 PM EST